MDS-445 Magrolimab In Combination With Azacitidine for Patients With Untreated Higher-Risk Myelodysplastic Syndromes (HR MDS): 5F9005 Phase 1b Study Results (2022)

First Author: Sallman D
Attributed to:  Biology and Treatment of Human Myeloid Cancers funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s2152-2650(22)01415-x

Publication URI: https://api.elsevier.com/content/abstract/scopus_id/85138201748

Type: Journal Article/Review

Parent Publication: Clinical Lymphoma Myeloma and Leukemia